Sanofi: Currency Moves Hurt Sales

Your next video will start in

Recommended Videos

  • Info

  • Comments


Oct. 30 (Bloomberg) -- Bloomberg’s Sam Fazeli reports on Sanofi earnings and the outlook for the pharmaceutical sector. He speaks on Bloomberg Television’s “Countdown.” (Source: Bloomberg)


One of the key ones of the vaccine issue.

We have known about this.

They have had a supply shortage which has impacted sales.

We have a carryover of the problem from brazil in terms of the generic sale they had in the country.

That is apparently turning around.

Obviously, we have foreign exchange and the impact of china.

How has that affected business?

It depends on which company you look at.

They had no evidence that the probe had affected them.

I don't think they are being mentioned as directly involved in these allegations.

Glaxosmithkline reported the biggest impact which is sensible because they were at the epicenter of this story.

Sanofi are suggesting there has been an impact on their business.

Structurally, they are losing

This text has been automatically generated. It may not be 100% accurate.


BTV Channel Finder


ZIP is required for U.S. locations

Bloomberg Television in   change